Harrow (HROW) EPS (Diluted) Growth (3y) (2019 - 2026)
Harrow (HROW) EPS (Diluted) Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 3.25% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.66% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 11.56% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -35.09% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 13.29% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 36.48% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Harrow | 1.53 Bn | 1.45 Bn | 50.36 Mn | -49.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -49.33% |
| Mar 31, 2026 | -50.08% |
| Dec 31, 2025 | 94.53% |
| Sep 30, 2025 | 28.28% |
| Jun 30, 2025 | 36.84% |
| Mar 31, 2025 | -76.97% |
| Dec 31, 2024 | 39.16% |
| Sep 30, 2024 | 27.26% |
| Jun 30, 2024 | -19.18% |
| Mar 31, 2024 | -269.46% |
| Dec 31, 2023 | -102.64% |
| Sep 30, 2023 | -33.92% |
| Jun 30, 2023 | -147.55% |
| Mar 31, 2023 | 24.00% |
| Dec 31, 2022 | -26.87% |
| Sep 30, 2022 | 19.59% |
| Jun 30, 2022 | -33.53% |
| Mar 31, 2022 | -30.26% |
| Dec 31, 2021 | -33.13% |
| Sep 30, 2021 | -41.47% |